排序方式: 共有1条查询结果,搜索用时 0 毫秒
1
1.
The transforming growth factor-β(TGF-β) plays a crucial role in the beginning and progression of fibrosis in various organ systems such as lung, heart, liver and kidney. TGF-β type I receptor kinase(activin receptor-like kinase 5, ALK5) inhibitors might have potential activity for the treatment of relevant diseases. In this paper, the three-dimensional quantitative structure-activity relationship(3 D-QSAR) including comparative molecular field analysis(Co MFA) and comparative molecular similarity indices analysis(Co MSIA) were used to analyze the structural requirements based on a dataset of 123 4-([1,2,4]Triazolo[1,5-α]pyridine-6-yl)-5(3)-(6-methylpyridin-2-yl)imidazole analogues which acted as ALK5 inhibitors. The obtained Co MFA model(q~2 = 0.652, r~2 = 0.876, r~2 pred = 0.845) and Co MSIA model(q~2 = 0.648, r~2 = 0.884, r~2 pred = 0.853) were robust and satisfactory. The predictive ability of the derived models was validated using a test set of 28 compounds. Additionally, potentially important structural features required to enhance activity were also elucidated by the contour maps derived from Co MFA and Co MSIA models. The results will be helpful to guide drug design strategies aimed at obtaining potent and selective ALK5 inhibitors. 相似文献
1